CArPEM: Cardiac Arrest Post-Discharge ECG Monitoring

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05337371
Collaborator
(none)
100
11

Study Details

Study Description

Brief Summary

The primary aim is to conduct a prospective observational cohort study to analyze the incidence of serious arrhythmic events that occur within 14 days after hospital discharge in patients who had been hospitalized for cardiac arrest caused by acute myocardial infarction. Cardiac arrythmias following hospital dischagre will be detected with Philips ePatch® 2.0 for 14 days.

Condition or Disease Intervention/Treatment Phase
  • Device: ECG patch (Philips ePatch® 2.0)

Detailed Description

Approximately 60,000 patients suffer from out-of-hospital cardiac arrest in Germany every year. Areas of myocardial ischemia may induce cardiac arrythmias, such as atrial fibrillation, ventricular tachycardia or ventricular fibrillation, which are known arrhythmic complications following cardiac arrest. Additionally, an imbalance in electrolytes as well as an increased use of inotropic or vasoactive medication as part of post-resuscitation care in the intensive care unit (ICU) may further increase the risk of cardiac arrythmias. 80% of cardiac arrythmias occur within 24 hours after cardiac arrest in the ICU. Patients with cardiac arrythmias following cardiac arrest have an increased mortality risk. Therefore, patients with cardiac arrest are monitored closely with telemetric monitors in the hospital, revascularized early and treated with beta-blockers, statins and renin-angiotensin-aldosterone antagonists to enhance myocardial remodeling and to decrease the rate of cardiac arrythmias. As soon as the patients are discharged from the hospital, no telemetric ECG monitoring can be provided. Therefore, the incidence of early cardiac arrythmias, which occur within 14 days after hospital discharge after treatment for cardiac arrest, remains unclear.

We plan to include 100 adult patients (≥18 years and ≤80 years) who survived cardiac arrest caused by acute myocardial infarction within the past 10 days. Patients with a left-ventricular ejection fraction between 36 to 50% and with sinus rhythm at the time of hospital discharge will be enrolled in this study. Patients who are suitable for implantable cardioverter-defibrillators (ICD) or pacemakers, with known paroxysmal or persistent atrial fibrillation, known inability to comply with follow-up or known pregnancy will not be enrolled.

Primary aim: The primary aim is to conduct a prospective observational cohort study to analyze the incidence of serious arrhythmic events that occur within 14 days after hospital discharge in patients who had been hospitalized for cardiac arrest caused by acute myocardial infarction. Cardiac arrythmias following hospital dischagre will be detected with Philips ePatch® 2.0 for 14 days.

Secondary aims: The secondary aim is to analzye the incidence of sinus arrest, atrial fibrillation, higher degree AV-block, ventricular tachycardia or fibrillation, all-cause mortality, cardiovascular mortality, stroke, systemic arterial thromboembolism and unplanned hospitalizations for decompensated heart failure within 14 days after discharge from the index hospital stay.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Incidence of Early Cardiac Arrythmias Following Hospital Discharge After Cardiac Arrest Monitored With Philips ePatch® 2.0
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Philips ePatch® 2.0

Patients who are discharged from the hospital with ECG patch (Philips ePatch® 2.0).

Device: ECG patch (Philips ePatch® 2.0)
The ECG patch will be put on the patients chest to monitor cardiac activity for a total time period of 14 days after cardiac arrest.

Outcome Measures

Primary Outcome Measures

  1. Incidence of serious cardiac arrythmias [Cardiac arrythmias within 14 days after hospital discharge from index hospital stay following cardiac arrest event.]

    Cardiac arrythmias monitored with Philips ePatch 2.0

Secondary Outcome Measures

  1. Incidence of sinus arrest, atrial fibrillation, higher degree AV-block, ventricular tachycardia or fibrillation [Cardiac arrythmias within 14 days after hospital discharge from index hospital stay following cardiac arrest event.]

    Cardiac arrythmias monitored with Philips ePatch 2.0

  2. All-cause mortality [Mortality due to any cause within 14 days after hospital discharge from index hospital stay following cardiac arrest event.]

    Mortality due to any cause

  3. Cardiovascular mortality [Mortality due to a cardiavascular cause within 14 days after hospital discharge from index hospital stay following cardiac arrest event.]

    Mortality due to a cardiavascular cause

  4. Stroke [Stroke within 14 days after hospital discharge from index hospital stay following cardiac arrest event.]

    Incidence of stroke

  5. Systemic arterial thromboembolism [Systemic arterial thromboembolism within 14 days after hospital discharge from index hospital stay following cardiac arrest event.]

    Incidence of systemic arterial thromboembolism

  6. Unplanned hospitalizations for decompensated heart failure [Unplanned hospitalizations for decompensated heart failure within 14 days after hospital discharge from index hospital stay following cardiac arrest event.]

    Unplanned hospitalizations for decompensated heart failure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age: 18-80 years

  • Cardiac arrest due to acute myocardial infarction

  • Cardiac arrest ≤10 days ago

  • Left-ventricular ejecion fraction at hospital discharge: 36-50%

  • Sinus rhythm at hospital discharge

  • Optimal medical therapy

Exclusion Criteria:
  • Non-adult patients

  • Cardiac arrest due to another cause other than acute myocardial infarction

  • Philips ePatch® 2.0 not applicable

  • ICD or pacemaker indication

  • Known paroxysmal or persistent atrial fibrillation

  • Inability to comply with follow-up- Pregnancy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Charite University, Berlin, Germany

Investigators

  • Study Director: Carsten Skurk, MD, Charité - University Hospital Berlin
  • Principal Investigator: Tharusan Thevathasan, MD, Charité - University Hospital Berlin

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tharusan Thevathasan, Dr., Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT05337371
Other Study ID Numbers:
  • Cardiac Arrest ECG
First Posted:
Apr 20, 2022
Last Update Posted:
Apr 20, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2022